Why the study?
Does heparin affect the serum binding of propranolol in patients with acute myocardial infarction?
Does heparin affect the serum binding of propranolol in patients with acute myocardial infarction?
Heparin administration decreases the serum binding of propranolol to lipoproteins in non-fasting subjects, likely by activating lipoprotein lipase.
Answers are grounded in this paper and cite their sources.
Heparin may alter propranolol levels in AMI patients; small cohort leaves open need for monitoring or adjustment.
1 Binding of propranolol in vitro was determined in sera from 38 non-fasting patients 4-6 days after an acute myocardial infarction.The binding of propranolol was significantly lower in 12 patients receiving a subcutaneous heparin injection than in 26 patients receiving warfarin. 2The binding of propranolol in sera from 9 geriatric patients without any acute diseases and 10 young, healthy subjects was similar to that of patients with acute myocardial infarction receiving heparin.3 Mean serum concentration of a,-acid glycoprotein was similar in the four different groups of individuals. 4For all subjects, the binding of propranolol was positively correlated to serum concentrations of a, -acid glycoprotein. 5In the patients with myocardial infarction the binding was negatively correlated to serum concen- trations of non-esterified fatty acids.Mean serum concentrations of non-esterified fatty acids was significantly higher in the patients receiving heparin than those receiving warfarin.6 Addition of heparin and palmitic acid to serum in vitro did not affect the binding of propranolol. 7The effect of heparin on binding variations was observed more closely in three non-fasting patients with myocardial infarction.Serum binding of propranolol and concentrations of chylomicrons and pre-,8-lipoproteins were significantly reduced after a subcutaneous heparin injection of 5,000 iu, while serum concentrations of non-esterified fatty acids increased threefold.Concentrations of a,-acid glycoprotein and albumin were unchanged.Changes in binding of propranolol was closely correlated to concomitant changes in the triglyceride-rich lipoproteins. 8These observations indicate that propranolol is bound to both triglyceride-rich lipoproteins and a, -acid glycoprotein in serum.Even smaller doses of heparin activate lipoprotein lipase and decrease binding of propranolol to lipoproteins in non-fasting subjects.
No takes yet. Share an insight, caveat, or question.
Sager et al. (1981) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: